Global COVID-19 Diagnostics Market Report 2022: Testing is Moving into Physicians' Offices and the Home - Assay Volumes and 5-Year Market Size Outlook

News provided by

Jan 26, 2022, 12:15 ET

DUBLIN, Jan. 26, 2022 /PRNewswire/ -- The "Global COVID-19 Diagnostics Market Forecast by Technology, Product, Channel and Country: Assay Volumes and 5-Year Market Size Outlook" report has been added to ResearchAndMarkets.com's offering.

A new dynamic market is emerging for COVID-19-based diagnostics. Testing is moving into physicians' offices and even into the home.

Saliva tests? Handheld multiplex testers? Home based testing sticks? And what about the workplace market where safety is paramount? And what happens to the large laboratory capacity that was built up to handle a pandemic now in decline? Learn all about these changing markets in our latest report.

Revenue, testing volumes, technology, products and channels - they are all looked at in this complete report that provides detailed breakdowns by country and regions. Get on top of the situation quickly with market guides and situation analysis. The report includes five year market forecasts.

COVID-19 Diagnostics Recent Developments

LetsGetChecked Closes $150M Funding Round
Novacyt Gets CE Mark for Multigene SARS-CoV-2 Test, Launches RUO Variant Assay
Abbott Sees Sharp Decline in COVID-19 Test Revenue
Phosphorus Diagnostics Gets EUA for DTC C19 Test, Sample Collection Kit
NY Times Explores Multiplex Testing
Hologic Banking on MDx Acquisitions
Demand for Cepheid SARS-CoV-2 Point-of-Care Tests to Continue Through 2022
DiaSorin Acquires Luminex to Broaden MDx Portfolio, Expand US Presence
LumiraDx to Go Public Through SPAC
Eurofins Test Helps to ID Mutations
Roche Sees Growing Opportunities for Diagnostics
Roche to Acquire GenMark Diagnostics for $1.8B
Fulgent Genetics is to Use COVID-19 Testing Gains to Grow Clinical Sequencing
LexaGene Syndromic Panel Platform Lets Labs Customize Targets
FDA Grants EUAs for DTC Sample Collection Kit, Two Molecular Tests
At-Home Infectious Disease Test Developer Lucira Health Goes Public

Diagnostic Company Profiles

Abacus Diagnostica
Abbott Diagnostics
Accelerate Diagnostics
Acces Bio
Advanced Biological Laboratories
Agena Bioscience, Inc
Agilent/Dako
Altona Diagnostics
Alveo Technologies
Anatolia Geneworks
Applied BioCode
Applied DNA Sciences
Assurance Scientific Laboratories
Aus Diagnostics
Autobio Diagnostics
Beckman Coulter Diagnostics
Becton, Dickinson and Company
BGI Genomics Co. Ltd
BillionToOne
Binx Health
Biocartis
Biodesix Inc
BioFire Diagnostics (bioMerieux)
Biolidics Ltd
bioMerieux Diagnostics
Bioneer Corporation
Bio-Rad Laboratories, Inc
Bio-Reference Laboratories
Bosch Healthcare Solutions GmbH
Cepheid (Danaher)
Chembio
Co Diagnostics
Color Genomics
Cue Health
Curetis N.V. / Curetis GmbH
Diagenode Diagnostics
Diasorin S.p.A
Ellume
Enzo Life Sciences, Inc
Everywell
Fluxergy
Fulgent Genetics
Fusion Genomics
Genedrive
Genetic Signatures
GenMark Dx (Roche)
Gold Standard Diagnostics
Hologic
Illumina
Immunexpress
Inflammatix
Janssen Diagnostics
Karius
Laboratory Corporation of America
Letsgetchecked
Lexagene
Luminex Corp
LumiraDx
Mammoth Biosciences
Mayo Clinic Laboratories
Mbio Diagnostics
Meridian Bioscience
Mesa Biotech (Thermo Fisher)
Mobidiag (Hologic)
Nanomix
Novacyt
Orasure
Ortho Clinical Diagnostics
Oxford Nanopore Technologies
Perkin Elmer
Primerdesign (Novacyt)
Prominex
Qiagen Gmbh
quantumdx.com
Quest Diagnostics
Quidel
Randox Toxicology
Roche Molecular Diagnostics
SD Biosensor
Seegene
Sherlock Biosciences
Siemens Healthineers
Sona Nanotech
SpeeDx
Thermo Fisher Scientific Inc
Veredus Laboratories
Vircell
Visby Medical
YD Diagnostics
Zhejiang Orient Gene Biotech

Scope of the Report

Technology

PCR
PCR Multiplex
Sequencing
Antibody
Antigen

Products

Instruments
Reagents & Kits
Extraction
Collection

Channels

Public
Hospital
Clinic
Workplace
DTC/OTC
Wastewater

For more information about this report visit https://www.researchandmarkets.com/r/ui2zn4

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets